Nursing Spectrum Nurseweek
» Subscribe «

Nurse.com

Search Courses
Search For:

Search By:
User Login
Username or Email:
Password:
keep me logged in?
Login Help Create New Account
CE Tools
Recommendations
CE Resources
CE Home > Endocrinology > CE378-60 From Lizards and Laboratories: New Diabetes Options
Advanced Practice Course
CE378-60b · 1.0 hr
From Lizards and Laboratories: New Diabetes Options
Author: Susanne J. Danis, RN, MSN, ARNP-C, CDE, CRRN

Online Options
Online Course Start Course Take Test $10.00
Offline Options
Book Buy Book $10.00 + shipping & handling
Objectives

The goal of this program is to enhance nurses’ ability to care for patients taking new injectable classifications of medications for diabetes. After studying the information presented here, you will be able to —

  • Describe the roles of amylin and the human incretin hormone GLP-1 in regulating blood glucose levels.
  • Identify three benefits of pramlintide acetate (Symlin) and exenatide (Byetta) injection therapy.
  • Discuss three nursing interventions to help patients adjust to and properly use pramlintide or exenatide therapy.
About Us • Contact Us • Terms of Service • Subscriptions • Advertise • Privacy